Lexicon Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Lexicon Pharmaceuticals
LXRX Stock  USD 1.32  0.00  0.00%   
Lexicon Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Lexicon Pharmaceuticals' valuation are provided below:
Gross Profit
-4.9 M
Profit Margin
(0.97)
Market Capitalization
547.4 M
Enterprise Value Revenue
6.968
Revenue
70.9 M
We have found one hundred twenty available fundamental ratios for Lexicon Pharmaceuticals, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Lexicon Pharmaceuticals last-minute market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 392.3 M in 2026. Enterprise Value is likely to rise to about 360.4 M in 2026

Lexicon Pharmaceuticals Total Revenue

45.68 Million

Check Lexicon Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexicon Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 456.6 K, Interest Expense of 18.8 M or Total Revenue of 45.7 M, as well as many indicators such as Price To Sales Ratio of 6.5, Dividend Yield of 0.0 or PTB Ratio of 1.77. Lexicon financial statements analysis is a perfect complement when working with Lexicon Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Lexicon Stock
Check out the analysis of Lexicon Pharmaceuticals Correlation against competitors.
For more information on how to buy Lexicon Stock please use our How to Invest in Lexicon Pharmaceuticals guide.

Lexicon Pharmaceuticals Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets326.8 M343.2 M327.8 M
Pretty Stable
Short and Long Term Debt Total77.9 M124.7 M96.9 M
Pretty Stable
Total Current Liabilities48.4 M52 M53 M
Very volatile
Property Plant And Equipment Net6.3 M6.6 M15.8 M
Slightly volatile
Accounts Payable12.2 M17 M15.1 M
Very volatile
Cash134.6 M76.7 M169.8 M
Slightly volatile
Non Current Assets Total75 M47 M86 M
Slightly volatile
Non Currrent Assets Other314.6 K331.2 K1.2 M
Slightly volatile
Cash And Short Term Investments208.9 M273.7 M227.1 M
Very volatile
Net Receivables5.1 M4 M5.7 M
Very volatile
Common Stock Shares Outstanding386.4 M368 M148.5 M
Slightly volatile
Short Term Investments139 M197 M151 M
Very volatile
Non Current Liabilities Total101.3 M123.3 M122.8 M
Very volatile
Other Current Assets3.9 M4.1 M7.6 M
Slightly volatile
Other Stockholder Equity2.6 B2.4 B1.5 B
Slightly volatile
Total Liabilities149.7 M175.3 M175.8 M
Very volatile
Property Plant And Equipment Gross8 M8.5 M16.8 M
Slightly volatile
Total Current Assets223.7 M283.1 M239.4 M
Very volatile
Long Term Debt78.7 M115.3 M93.7 M
Slightly volatile
Common Stock Total Equity212.7 K217.3 K241 K
Slightly volatile
Property Plant Equipment1.8 M1.9 M14.4 M
Slightly volatile
Other Liabilities43.1 M26.8 M42.7 M
Slightly volatile
Good Will41.3 M51.2 M43.6 M
Slightly volatile
Intangible Assets41.5 M22.7 M35.9 M
Slightly volatile
Long Term Debt Total282.8 M269.3 M164.6 M
Slightly volatile
Capital Surpluse1.5 B2 B1.5 B
Slightly volatile
Deferred Long Term Liabilities52.6 M34.1 M40 M
Pretty Stable
Non Current Liabilities Other4.6 M4.9 M14.3 M
Slightly volatile
Short and Long Term Debt8.7 M10.5 M13.1 M
Slightly volatile
Net Invested Capital176.5 M221.6 M249.8 M
Slightly volatile
Net Working Capital124.8 M180.9 M172.9 M
Slightly volatile
Capital Stock438.3 K417.4 K176.8 K
Slightly volatile
Capital Lease Obligations4.8 M9.3 M2.9 M
Slightly volatile

Lexicon Pharmaceuticals Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization456.6 K480.6 K2.1 M
Slightly volatile
Total Revenue45.7 M28 M50.1 M
Very volatile
Other Operating Expenses145.1 M262.4 M142.9 M
Slightly volatile
Research Development97.2 M97.2 M93.5 M
Very volatile
Total Operating Expenses137.8 M261.7 M132.2 M
Slightly volatile
Selling General Administrative172.8 M164.6 M58.9 M
Slightly volatile
Non Operating Income Net Other1.9 M1.8 M1.6 M
Slightly volatile
Interest Income14.8 M14.1 M6.1 M
Slightly volatile
Reconciled Depreciation456.6 K480.6 K2.4 M
Slightly volatile
Extraordinary Items3.2 M3.6 M3.9 M
Slightly volatile

Lexicon Pharmaceuticals Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow24.5 M25.8 M69.4 M
Pretty Stable
Depreciation456.6 K480.6 K2.1 M
Slightly volatile
Capital Expenditures881.5 K927.9 K886.9 K
Slightly volatile
End Period Cash Flow69.9 M76.7 M76.1 M
Pretty Stable
Stock Based Compensation9.9 M15.5 M10.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.56.84373
Pretty Stable
Days Sales Outstanding57.936.7196.0049
Slightly volatile
Stock Based Compensation To Revenue0.370.398.5472
Pretty Stable
Capex To Depreciation1.821.741.0699
Slightly volatile
EV To Sales7.658.05349
Pretty Stable
Inventory Turnover2.282.442.6115
Slightly volatile
Days Of Inventory On Hand311157177
Pretty Stable
Sales General And Administrative To Revenue0.860.912.6539
Slightly volatile
Research And Ddevelopement To Revenue2.322.4547.4605
Pretty Stable
Capex To Revenue0.02840.02990.9936
Pretty Stable
Cash Per Share0.810.862.3037
Slightly volatile
Intangibles To Total Assets0.150.130.2145
Pretty Stable
Current Ratio7.066.265.8333
Pretty Stable
Receivables Turnover9.7810.2919.9111
Very volatile
Capex Per Share0.00350.00370.0748
Slightly volatile
Average Receivables2.7 M3.3 M3.6 M
Pretty Stable
Revenue Per Share0.110.09710.5184
Pretty Stable
Interest Debt Per Share0.420.451.0812
Slightly volatile
Debt To Assets0.190.330.3007
Pretty Stable
Graham Number4.414.965.4154
Slightly volatile
Operating Cycle110160206
Very volatile
Quick Ratio7.056.255.8126
Pretty Stable
Net Income Per E B T0.990.941.0012
Pretty Stable
Cash Ratio2.471.333.6869
Slightly volatile
Days Of Inventory Outstanding311157177
Pretty Stable
Days Of Sales Outstanding57.936.7196.0049
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.421.161.0636
Very volatile
Fixed Asset Turnover5.173.829.3567
Very volatile
Debt Ratio0.190.330.3007
Pretty Stable
Price Sales Ratio6.56.84373
Pretty Stable
Asset Turnover0.220.120.1423
Very volatile

Lexicon Pharmaceuticals Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap392.3 M212.7 M555.1 M
Slightly volatile
Enterprise Value360.4 M250.3 M511.1 M
Slightly volatile

Lexicon Fundamental Market Drivers

Lexicon Upcoming Events

7th of March 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Lexicon Pharmaceuticals Financial Statements

Lexicon Pharmaceuticals investors use historical fundamental indicators, such as Lexicon Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexicon Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue32.4 M20 M
Total Revenue28 M45.7 M
Cost Of Revenue554.4 K526.7 K
Stock Based Compensation To Revenue 0.39  0.37 
Sales General And Administrative To Revenue 0.91  0.86 
Research And Ddevelopement To Revenue 2.45  2.32 
Capex To Revenue 0.03  0.03 
Revenue Per Share 0.10  0.11 
Ebit Per Revenue(7.29)(7.66)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill

Additional Tools for Lexicon Stock Analysis

When running Lexicon Pharmaceuticals' price analysis, check to measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY